Novel agents for metastatic hormone-sensitive prostate cancer - a practice guide for urologists

被引：6
作者：
Thangasamy, Isaac A. [1 ,2 ]
Kwan, Edmond M. [3 ,4 ]
Teh, Jiasian [1 ]
Sathianathen, Niranjan [1 ]
Alghazo, Omar [1 ]
Siva, Shankar [5 ,6 ]
Azad, Arun [6 ]
Murphy, Declan G. [1 ,6 ]
机构：
[1] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia
[2] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[3] Monash Univ, Sch Clin Sci, Dept Med, Parkville, Vic, Australia
[4] Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia
[5] Peter MacCallum Canc Ctr, Div Radiat Oncol, Melbourne, Vic, Australia
[6] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
来源：
BJU INTERNATIONAL | 2020年 / 125卷 / 03期
关键词：
prostate cancer; chemotherapy; metastatic; hormone sensitive; androgen axis-targeted therapies; PostateCancer; PCSM; THERAPY;
D O I：
10.1111/bju.14936
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：342 / 345
页数：4
相关论文
共 7 条
  • [1] ARMSTRONG AJ, 2019, J CLIN ONCOL S, V37
  • [2] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Chi, Kim N.
    Agarwal, Neeraj
    Bjartell, Anders
    Chung, Byung Ha
    Pereira de Santana Gomes, Andrea J.
    Given, Robert
    Juarez Soto, Alvaro
    Merseburger, Axel S.
    Ozguroglu, Mustafa
    Uemura, Hirotsugu
    Ye, Dingwei
    Deprince, Kris
    Naini, Vahid
    Li, Jinhui
    Cheng, Shinta
    Yu, Margaret K.
    Zhang, Ke
    Larsen, Julie S.
    McCarthy, Sharon
    Chowdhury, Simon
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01) : 13 - 24
  • [3] Management of patients with advanced prostate cancer in the Asia Pacific region: "real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017
    Chiong, Edmund
    Murphy, Declan G.
    Akaza, Hideyuki
    Buchan, Nicholas C.
    Chung, Byung Ha
    Kanesvaran, Ravindran
    Khochikar, Makarand
    Letran, Jason
    Lojanapiwat, Bannakij
    Ng, Chi-fai
    Ong, Teng
    Pu, Yeong-Shiau
    Saad, Marniza
    Schubach, Kathryn
    Turkeri, Levent
    Umbas, Rainy
    Vu Le Chuyen
    Williams, Scott
    Ye, Ding-Wei
    Davis, Ian D.
    [J]. BJU INTERNATIONAL, 2019, 123 (01) : 22 - 34
  • [4] Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
    Davis, Ian D.
    Martin, Andrew J.
    Stockler, Martin R.
    Begbie, Stephen
    Chi, Kim N.
    Chowdhury, Simon
    Coskinas, Xanthi
    Frydenberg, Mark
    Hague, Wendy E.
    Horvath, Lisa G.
    Joshua, Anthony M.
    Lawrence, Nicola J.
    Marx, Gavin
    McCaffrey, John
    McDermott, Ray
    McJannett, Margaret
    North, Scott A.
    Parnis, Francis
    Parulekar, Wendy
    Pook, David W.
    Reaume, M. Neil
    Sandhu, Shahneen K.
    Tan, Alvin
    Tan, T. Hsiang
    Thomson, Alastair
    Tu, Emily
    Vera-Badillo, Francisco
    Williams, Scott G.
    Yip, Sonia
    Zhang, Alison Y.
    Zielinski, Robert R.
    Sweeney, Christopher J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02) : 121 - 131
  • [5] Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
    James, Nicholas D.
    Sydes, Matthew R.
    Clarke, Noel W.
    Mason, Malcolm D.
    Dearnaley, David P.
    Spears, Melissa R.
    Ritchie, Alastair W. S.
    Parker, Christopher C.
    Russell, J. Martin
    Attard, Gerhardt
    de Bono, Johann
    Cross, William
    Jones, Rob J.
    Thalmann, George
    Amos, Claire
    Matheson, David
    Millman, Robin
    Alzouebi, Mymoona
    Beesley, Sharon
    Birtle, Alison J.
    Brock, Susannah
    Cathomas, Richard
    Chakraborti, Prabir
    Chowdhury, Simon
    Cook, Audrey
    Elliott, Tony
    Gale, Joanna
    Gibbs, Stephanie
    Graham, John D.
    Hetherington, John
    Hughes, Robert
    Laing, Robert
    McKinna, Fiona
    McLaren, Duncan B.
    O'Sullivan, Joe M.
    Parikh, Omi
    Peedell, Clive
    Protheroe, Andrew
    Robinson, Angus J.
    Srihari, Narayanan
    Srinivasan, Rajaguru
    Staffurth, John
    Sundar, Santhanam
    Tolan, Shaun
    Tsang, David
    Wagstaff, John
    Parmar, Mahesh K. B.
    [J]. LANCET, 2016, 387 (10024) : 1163 - 1177
  • [6] Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
    Rydzewska, Larysa H. M.
    Burdett, Sarah
    Vale, Claire L.
    Clarke, Noel W.
    Fizazi, Karim
    Kheoh, Thian
    Mason, Malcolm D.
    Miladinovic, Branko
    James, Nicholas D.
    Parmar, Mahesh K. B.
    Spears, Melissa R.
    Sweeney, Christopher J.
    Sydes, Matthew R.
    NamPhuong Tran
    Tierney, Jayne F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 84 : 88 - 101
  • [7] Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Sweeney, Christopher J.
    Chen, Yu-Hui
    Carducci, Michael
    Liu, Glenn
    Jarrard, David F.
    Eisenberger, Mario
    Wong, Yu-Ning
    Hahn, Noah
    Kohli, Manish
    Cooney, Matthew M.
    Dreicer, Robert
    Vogelzang, Nicholas J.
    Picus, Joel
    Shevrin, Daniel
    Hussain, Maha
    Garcia, Jorge A.
    DiPaola, Robert S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08) : 737 - 746
1